Equillium, Inc.

EQ ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $57.2M $61.3M $30.3M $33.1M $11.5M $14.5M $18.1M $15.4M
Accounts Receivable — — — — — — $0 $5.0M
Inventory — — — — — — — —
Total Current Assets $58.0M $62.3M $31.0M $33.6M $12.0M $16.2M $25.0M $33.6M
Property, Plant & Equipment $188.0K $214.0K $164.0K $174.0K $201.0K $233.0K $262.0K $293.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $58.7M $63.1M $31.9M $34.5M $12.4M $16.7M $25.6M $34.5M
Liabilities
Accounts Payable $850.0K $1.3M $755.0K $1.1M $4.8M $3.1M $2.7M $3.7M
Total Current Liabilities $2.5M $3.3M $2.9M $3.1M $7.2M $6.0M $6.4M $11.1M
Long-Term Debt — — — — — — — —
Total Liabilities $2.7M $3.6M $3.3M $3.6M $7.3M $6.2M $6.5M $11.3M
Stockholders' Equity
Retained Earnings $-226.2M $-221.5M $-216.2M $-212.4M $-208.2M $-202.5M $-193.8M $-188.0M
Total Stockholders' Equity $56.0M $59.5M $28.6M $30.9M $5.1M $10.6M $19.1M $23.2M
← Newer Page 1 of 5 Older →